Parents

Parent newsletter

Past Articles

Meningitis
meningococcal disease update
By Mary Catherine King, Associate dean of students and health services

Bacterial (meningococcal) meningitis has recently been in the local news. Topics include the slightly higher risk for college students, especially those living in on-campus residence halls, behaviors that can promote the disease, and the availability of a meningococcal vaccine. The college takes this situation very seriously and has developed the following answers to some frequently asked questions about meningococcal disease

     

What is meningitis?
Meningitis is an inflammation of brain and spinal cord membranes caused by either viruses or bacteria; bacterial meningitis, the more serious but fortunately less common form of the disease, occupies the current focus of attention. Meningococcal meningitis progresses very rapidly and therefore requires early diagnosis and aggressive treatment with antibiotics.

What are the signs and symptoms of meningococcal disease?
Symptoms often mimic those of the flu, including high fever, severe headache, stiff neck, nausea, and lethargy. In advanced cases a diffuse purple rash may develop. We have notified all Reed students of these symptoms and instructed them to report immediately to the health center or go to the emergency room of a local hospital during off hours if these symptoms develop.

How many cases of meningococcal disease occur each year?
The disease strikes one per 100,000 for both the general population and students living off campus. The risk increases to three per 100,000 students living in on-campus housing. Approximately 100 cases of meningitis are reported in Oregon each year. Approximately 10 percent of those who contract the disease die; many others suffer permanent and debilitating damage to the brain, limbs, kidneys, or hearing.

 

Who is at risk?
The disease is spread through contact with an infected person’s oral secretions. Such contact includes sharing utensils or drinking glasses, kissing, and coughing. It also appears that smokers, those under physical stress, and IV drug users may be at increased risk for contracting the infection.

How effective is the meningococcal vaccine?
A partially effective vaccine is available to students who request it at a cost of approximately $70; most medical plans, however, will not cover this kind of preventative treatment. Over half of these cases reported in the Pacific Northwest are caused by a strain that is resistant to the vaccine. Although the college is not recommending widespread use of the vaccine at this time, students are encouraged to discuss this option with family and health care providers.